These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9878118)

  • 1. Prevention of experimental allergic encephalomyelitis by an antibody to CD45RB.
    Schiffenbauer J; Butfiloski E; Hanley G; Sobel ES; Streit WJ; Lazarovits A
    Cell Immunol; 1998 Dec; 190(2):173-82. PubMed ID: 9878118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of T cells with activated and memory phenotypes in inflammatory spinal cord lesions.
    Barten DM; Clark RB; Ruddle NH
    J Immunol; 1995 Dec; 155(11):5409-18. PubMed ID: 7594558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-T cell monoclonal antibodies in vivo. II. Modulation of acute and chronic experimental allergic encephalomyelitis (EAE) in guinea pigs.
    Sobel RA; Blanchette BW; Russo MA; Williams AM; Colvin RB
    J Immunol; 1987 Apr; 138(8):2507-13. PubMed ID: 3494072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis.
    Matejuk A; Bakke AC; Hopke C; Dwyer J; Vandenbark AA; Offner H
    J Neurosci Res; 2004 Jul; 77(1):119-26. PubMed ID: 15197745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen inhibition of EAE involves effects on dendritic cell function.
    Liu HY; Buenafe AC; Matejuk A; Ito A; Zamora A; Dwyer J; Vandenbark AA; Offner H
    J Neurosci Res; 2002 Oct; 70(2):238-48. PubMed ID: 12271473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody against T-cell receptor alphabeta induces self-tolerance in chronic experimental autoimmune encephalomyelitis.
    Lavasani S; Dzhambazov B; Andersson M
    Scand J Immunol; 2007 Jan; 65(1):39-47. PubMed ID: 17212765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
    Skundric DS; Dai R; Zakarian VL; Bessert D; Skoff RP; Cruikshank WW; Kurjakovic Z
    J Neurosci Res; 2005 Mar; 79(5):680-93. PubMed ID: 15682385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential cytokine and chemokine production characterizes experimental autoimmune meningitis and experimental autoimmune encephalomyelitis.
    Perrin PJ; Rumbley CA; Beswick RL; Lavi E; Phillips SM
    Clin Immunol; 2000 Feb; 94(2):114-24. PubMed ID: 10637096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential role of TGF-beta in the natural resistance to experimental allergic encephalomyelitis in rats.
    Cautain B; Damoiseaux J; Bernard I; van Straaten H; van Breda Vriesman P; Boneu B; Druet P; Saoudi A
    Eur J Immunol; 2001 Apr; 31(4):1132-40. PubMed ID: 11298338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of resistance to active experimental allergic encephalomyelitis by myelin basic protein-specific Th2 cell lines generated in the presence of glucocorticoids and IL-4.
    Ramírez F; Mason D
    Eur J Immunol; 2000 Mar; 30(3):747-58. PubMed ID: 10741389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late B cell depletion with a human anti-human CD20 IgG1κ monoclonal antibody halts the development of experimental autoimmune encephalomyelitis in marmosets.
    Kap YS; van Driel N; Blezer E; Parren PW; Bleeker WK; Laman JD; Craigen JL; 't Hart BA
    J Immunol; 2010 Oct; 185(7):3990-4003. PubMed ID: 20739677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined treatment of acute EAE in Lewis rats with TNF-binding protein and interleukin-1 receptor antagonist.
    Wiemann B; Van GY; Danilenko DM; Yan Q; Matheson C; Munyakazi L; Ogenstad S; Starnes CO
    Exp Neurol; 1998 Feb; 149(2):455-63. PubMed ID: 9500957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats.
    Xu LY; Yang JS; Huang YM; Levi M; Link H; Xiao BG
    Clin Immunol; 2000 Sep; 96(3):205-11. PubMed ID: 10964538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new role for interleukin-7 in the induction of LFA-1 and VLA-4 adhesion molecules in Phorbol 12myristate 13acetate activated CD4+ CD23+ T-cell subset.
    Fratazzi C; Carini C
    Clin Exp Allergy; 1997 Nov; 27(11):1335-43. PubMed ID: 9420139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that Fas and FasL contribute to the pathogenesis of experimental autoimmune encephalomyelitis.
    Dittel BN
    Arch Immunol Ther Exp (Warsz); 2000; 48(5):381-8. PubMed ID: 11140465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of experimental autoimmune encephalomyelitis with a TNF binding protein (TNFbp) correlates with down-regulation of VCAM-1/VLA-4.
    Selmaj K; Walczak A; Mycko M; Berkowicz T; Kohno T; Raine CS
    Eur J Immunol; 1998 Jun; 28(6):2035-44. PubMed ID: 9645385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental autoimmune encephalomyelitis in NF-kappa B-deficient mice:roles of NF-kappa B in the activation and differentiation of autoreactive T cells.
    Hilliard B; Samoilova EB; Liu TS; Rostami A; Chen Y
    J Immunol; 1999 Sep; 163(5):2937-43. PubMed ID: 10453042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis.
    Theien BE; Vanderlugt CL; Eagar TN; Nickerson-Nutter C; Nazareno R; Kuchroo VK; Miller SD
    J Clin Invest; 2001 Apr; 107(8):995-1006. PubMed ID: 11306603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A natural anti-T-cell receptor monoclonal antibody protects against experimental autoimmune encephalomyelitis.
    Fernández-Malavé E; Stark-Aroeira L
    J Neuroimmunol; 2011 May; 234(1-2):63-70. PubMed ID: 21396721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NOS2 regulates cytokine production and VLA-4 expression in experimental autoimmune encephalomyelitis.
    Cross AH; Ramsbottom MJ; Lyons JA
    J Neuroimmunol; 2006 Apr; 173(1-2):79-86. PubMed ID: 16448705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.